[an error occurred while processing this directive]
BBC News
watch One-Minute World News
Last Updated: Monday, 15 November, 2004, 11:37 GMT
US drug maker buys Israeli firm
Generic drugs
Generic drug-makers keep costs low by using expired patents
US consumer healthcare company Perrigo is to buy Israeli drug-maker Agis for $818m (441.5m) in cash and stock.

The deal will create a firm with annual sales of $1.3bn, and is the second largest US takeover in Israel.

Perrigo is the US's largest maker of over-the-counter, store-branded pharmaceuticals, and is looking to increase its generic drug production.

Demand for generics, chemically-similar copies of branded drugs, is growing as governments and consumers cut costs.

Generics are a way of bringing cheap medicines to developing nations, and drug-makers often keep costs low by using expired patents.

'Perfect partner'

"With its prescription generic drugs, active pharmaceutical ingredients and over-the-counter pharmaceuticals business, Agis is the perfect partner to facilitate growth," Perrigo chairman and CEO Dave Gibbons told Reuters news agency.

Agis, which already sells generic pharmaceuticals in the US, posted third-quarter net profits of 41.2m shekels ($9.3m) on Monday, compared with 34.5m a year earlier, Reuters reported.

Under the terms of the agreement, Perrigo will pay Agis stockholders 0.8011 share of Perrigo stock and $14.93 in cash for each Agis share.

The offer values Agis at $29.87 a share, 21.4% more than the stock's closing price yesterday. The deal is expected to close during the second quarter of 2005.

Perrigo stockholders will own about 77% of the combined company, and Agis stockholders will own about 23%.

Agis chairman Mori Arkin will stay on at the company as vice-chairman of Perrigo's board of directors.


SEE ALSO:
Cut-price competition hits Glaxo
27 Jul 04 |  Business
Is the WTO drugs deal flawed?
07 Sep 03 |  Health
Copycat drugs send profits soaring
17 Jan 03 |  Business
US plans boost for generic drugs
21 Oct 02 |  Business
Court bars copycat drug makers
14 Oct 02 |  Business


RELATED INTERNET LINKS:
The BBC is not responsible for the content of external internet sites


PRODUCTS AND SERVICES

News Front Page | Africa | Americas | Asia-Pacific | Europe | Middle East | South Asia
UK | Business | Entertainment | Science/Nature | Technology | Health
Have Your Say | In Pictures | Week at a Glance | Country Profiles | In Depth | Programmes
Americas Africa Europe Middle East South Asia Asia Pacific